MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'hypoactive sexual desire'. Sat, 03 Sep 2011 02:35:59 +0100 http://www.medworm.com/index.php?rid=4082331&cid=t_438589_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F1PftGII3ISA%2F Earlier this year, Boehringer ingelheim helped reignite controversy over female sexual dysfunction – whether Hypoactive Sexual Desire Disorder is truly a disorder and the extent to which medication may be a feasible solution - with an aggressive marketing plan for a pill called flibanserin. The episode encapsulated the debate over medicine versus marketing and occurred during a run-up to a closely watched FDA advisory committee meeting this past summer in which the drugmaker failed to win a recommendation (look here). Since then, Boehringer ditched plans to seek FDA approval (see this). And so we spoke with Ray Moynihan, an Australian journalist, who recently published a book called ‘Sex, Lies & Pharmaceuticals’ and has written extensively on this issue, about any lessons learne... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4082331 Tue, 19 Oct 2010 12:14:41 +0100 4082331 http://www.medworm.com/index.php?rid=4045391&cid=t_438589_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FH7eAM_JKqhU%2F Three months after an FDA panel voted against a pill that was designed to treat Hypoactive Sexual Desire Disorder in women, Boehringer Ingelheim has decided to discontinue development. The move caps a huge setback for the drugmaker, which geared up an enormous publicity effort to promote a pill that many were - to Boehringer’s delight - calling a female Viagra. Instead, the FDA panel voted 10-to-1 that flibanserin was not effective in increasing female libido, and then voted unanimously that potential side effects, such as depression and a loss of consciousness and depression, were unacceptable. The pill did show a statistically difference in generating sexually satisfying experiences compared with a placebo, but there was no statistically significant improvement on the co-primary en... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4045391 Fri, 08 Oct 2010 12:32:38 +0100 4045391 http://www.medworm.com/index.php?rid=3983397&cid=t_438589_88_f&fid=38129&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Flifeinthefastlane%2FWZHV%2F%7E3%2FR0-31-0gRRU%2F Ray Moynihan teams up with drug assessment specialist Barbara Mintzes to investigate the creation of female sexual dysfunction or FSD, and the marketing machine that promises to “cure” it. Against a backdrop of virtual intercourse, online porn, and burgeoning Viagra sales, Sex, Lies, and Pharmaceuticals reveals how women’s sexual difficulties are being repackaged as symptoms of a new disorder, and the medicalization of ordinary life. (Source: Life in the Fast Lane) Life in the Fast Lane blogs http://www.medworm.com/rss/comments.php?id=3983397 Mon, 20 Sep 2010 03:55:29 +0100 3983397 http://www.medworm.com/index.php?rid=3733080&cid=t_438589_87_f&fid=38368&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FDisruptiveWomenInHealthCare%2F%7E3%2FiLuybO-gO8g%2F The Society for Women’s Health Research cordially invites you to attend: WHAT A DIFFERENCE AN X MAKES: THE STATE OF WOMEN’S HEALTH RESEARCH Friday, July 16, 2010 9:00 am – 4:00 pm Barbara Jordan Conference Center Kaiser Family Foundation 1330 G Street, NW, Washington, DC 20005 This scientific conference will highlight advances in sex differences research and its implications on health and disease. Registration fee for the conference is $35 per person, $20 for students. RSVP NOW! Topics and speakers include: Pain and the Musculoskeletal System – Carmen R. Green, MD and Mary O’Connor, MD The Brain - Kathryn M. Magruder, MPH, PhD and Cerise Elliott, PhD The Immune System – Sabra Klein, PhD and Rhonda Voskuhl, MD Cardio/Cerebrovascular Disease and Therape... Disruptive Women in Health Care blogs http://www.medworm.com/rss/comments.php?id=3733080 Wed, 07 Jul 2010 13:48:01 +0100 3733080 http://www.medworm.com/index.php?rid=3706670&cid=t_438589_87_f&fid=38368&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FDisruptiveWomenInHealthCare%2F%7E3%2FNf6GszCZ5So%2F By Phyllis Greenberger. I just love this—it happens every time. Leave it to the news media to decide whether something is a real health issue or not. That they know little or nothing about the medical condition doesn’t stop them. The latest example is Hypoactive sexual desire disorder (HSDD), a condition that affects as many as 20% of women. It is a loss of desire or libido without any other concurrent medical condition. But, if these journalists (and I use that term loosely) haven’t heard of a condition, especially this one because it has to do with female sexual dysfunction, they are sure a drug company made it up. I heard this with PMDD, fibromyalgia, restless leg syndrome, chronic fatigue syndrome. The media and a few doctors said there was no such thing in each of these situatio... Disruptive Women in Health Care blogs http://www.medworm.com/rss/comments.php?id=3706670 Mon, 28 Jun 2010 10:57:55 +0100 3706670 http://www.medworm.com/index.php?rid=3676895&cid=t_438589_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F2XOY_lJHta0%2F After weeks of anticipation and debate, an FDA advisory committee decided a Boehringer Ingelhim pill that was tested for treating Hypoactive Sexual Desire Disorder in women was neither safe nor effective. The voting was rather stark - all 11 panelists decided the side effects were unacceptable, and 10 ruled the pill, known as flibanserin, is not effective. The outcome is hardly surprising, given concerns outlined by FDA reviewers in briefing documents that were released prior to the meeting. The pill did show a statistically difference in generating sexually satisfying experiences compared with a placebo (read the report) - women reported an average of 4.5 per month compared with 2.8 before taking the pill, while the rate jumped to 3.7 for those on placebo. But there was no statistically s... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3676895 Fri, 18 Jun 2010 20:06:59 +0100 3676895 http://www.medworm.com/index.php?rid=3676892&cid=t_438589_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F06%2Fsex-pharmaceuticals-and-selling.html This October I will be in Amsterdam enjoying the sights and pleasures that city has to offer. But I am not planning to buy sex or to smoke pharmaceutical substances. I do plan, however, to attend and make a presentation at the Selling Sickness conference hosted by Healthy Skepticism (Netherlands), assisted by the Dutch Institute for Rational Use of Medicine and Healthy Skepticism (International). The sponsors include the Dutch Ministry of Health and the Dutch Health Care Inspectorate. You can find the program here.I look forward to this conference because "Female sexual dysfunction will be used as a case study to explore problems with disease promotion as well as policy options." Ray Moynihan, journalist, co-author of the book "Selling Sickness: How The World's Biggest Pharmaceutical Compa... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=3676892 Fri, 18 Jun 2010 18:44:00 +0100 3676892 http://www.medworm.com/index.php?rid=3672033&cid=t_438589_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FTTuyvbBKQg8%2F For the past month, The Discovery Channel has been running on its web site a four-part series called ‘Understanding Female Sexual Desire.’ It has a CME label alongside the title - continuing medical education - although the network describes the programming as patient education. The sponsor is noted at the outset and it happens to be Boehringer Ingelheim, which tomorrow hopes to convince an FDA advisory panel to approve a pill to treat a disorder it calls female sexual dysfunction (see this). The series explores Hypoactive Sexual Desire Disorder, which is listed in the Diagnostic and Statistical Manual of Mental Disorders, and Discovery is careful to not mention any drug, including flibanserin, the Boehringer pill, since none is approved to treat the condition. What role, if a... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3672033 Fri, 18 Jun 2010 01:38:37 +0100 3672033 http://www.medworm.com/index.php?rid=3666221&cid=t_438589_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FjG93Fxo6YPA%2F File this under ‘from hot to cold.’ On the eve of what will be a closely watched and controversial FDA advisory committee meeting on Friday, a team of agency reviewers found the Boehringer Ingelheim pill, which is called flibanserin and was tested to treat Hypoactive Sexual Desire Disorder, failed to meet agreed-upon criteria to establish effectiveness in two company studies. Specifically, there was no statistically significant improvement on the co-primary endpoint of sexual desire, although the pill did show a statistically difference in generating sexually satisfying experiences compared with a placebo (read the report here). The FDA Division of Reproductive/Urologic Drug Products cited several points of “major concern” heading into the meeting: The trials didn&#... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3666221 Wed, 16 Jun 2010 15:45:53 +0100 3666221 http://www.medworm.com/index.php?rid=3652688&cid=t_438589_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fv26Nzb8y-10%2F Next week, an FDA advisory committee will meet to review a Boehringer Ingelheim pill to tackle FSD, or female sexual dysfunction. This would be the first such drug for the US market and you will see a lot in the media next week. However, a growing group of psychologists, academics and public health advocates contend FSD isn’t an authentic medical condition, or at least not the sort of problem that should be treated with drugs (one critic is about to publish a book). Bandied about but never proven is the statistic that 43 percent of women suffer from this affliction (background). So we spoke with Leonore Tiefer, a clinical associate professor of psychiatry at the New York University School of Medicine, who heads the NewViewCampaign, a grassroots effort devoted to challenging the ‘me... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3652688 Fri, 11 Jun 2010 15:36:59 +0100 3652688 http://www.medworm.com/index.php?rid=3617801&cid=t_438589_87_f&fid=34872&url=http%3A%2F%2Fblisstree.com%2Ffeel%2Fwomen-and-sex-hypoactive-sexual-desire-disorder%2F photo: Thinkstock According to a recent survey by the Society for Women’s Health Research, both men and women agree that sexual health is vital to a woman’s health and well being. But do all women know that a decrease in sexual desire could be a sign that their sexual health is suffering? Many people write off low libido as the result of stress at work or at home, but if it happens repeatedly, it could be because of Hypoactive Sexual Desire Disorder (HSDD). A new initiative called “Sex Brain Body,” spearheaded by actress Lisa Rinna (Days of Our Lives, Dancing With the Stars) and sex and relationship expert Dr. Laura Berman, focuses on educating women about their sexual health, which includes HSDD. Though surveys show that women are concerned about low libido, very... Healthbolt blogs http://www.medworm.com/rss/comments.php?id=3617801 Mon, 24 May 2010 20:48:56 +0100 3617801 http://www.medworm.com/index.php?rid=3595543&cid=t_438589_87_f&fid=34872&url=http%3A%2F%2Fblisstree.com%2Ffeel%2Fwomen-and-sex-hypoactive-sexual-desire-disorder%2F photo: Thinkstock According to a recent survey by the Society for Women’s Health Research, both men and women agree that sexual health is vital for a woman’s health and well being. But do all women know that a decrease in sexual desire could be a sign that their sexual health is suffering? Many people write off low libido as the result of stress at work or at home, but if it happens repeatedly, it could be because of Hypoactive Sexual Desire Disorder (HSDD). A new initiative called “Sex Brain Body,” spearheaded by actress Lisa Rinna and sex and relationship expert Dr. Laura Berman, focuses on educating women about their sexual health, which includes HSDD. Though surveys show that women are concerned about low libido, very few actually bring it up to either their p... Healthbolt blogs http://www.medworm.com/rss/comments.php?id=3595543 Mon, 24 May 2010 20:48:56 +0100 3595543 http://www.medworm.com/index.php?rid=2999485&cid=t_438589_87_f&fid=34872&url=http%3A%2F%2Fwww.blisstree.com%2Fhealthbolt%2Fviagra-for-women-well-sort-of%2F Viagra for men – and the similar drugs that followed after – is a huge, huge money maker for big pharmaceuticals. You have to give them credit. They found a need and they filled it; they rose to the challenge (pun intended ). But now, the target is women. Women do experience sexual dysfunction. Many women would love to have satisfying sex lives but don’t because of various issues. While some researchers are actively working on medications to help women with their sexual desire, some discover a treatment by accident, as did researchers from the University of North Carolina at Chapel Hill School of Medicine The researchers were looking at a medication called flibanserin, an antidepressant. But what the researchers found by pooling information from three separate trials, wa... Healthbolt blogs http://www.medworm.com/rss/comments.php?id=2999485 Tue, 17 Nov 2009 00:53:09 +0100 2999485